The diversification of B-cell clones occurs after autoantigen exposure and in SLE, the B-cell receptor (BCR) “repertoire”, as an expression of autoantibody response to multiple autoantigens, is distinct from other immune-mediated disorders [50]. This evidence concerns the gene BCR and systemic lupus erythematosus.